Photo of Paul Crowe
  • Room 0B.022 - CEM

    United Kingdom

20042012
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paul Crowe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Osteopontin Medicine & Life Sciences
pioglitazone Medicine & Life Sciences
Yin-Yang Medicine & Life Sciences
CCAAT-Enhancer-Binding Proteins Medicine & Life Sciences
Calcitriol Receptors Medicine & Life Sciences
Retinitis Pigmentosa Medicine & Life Sciences
beta Catenin Medicine & Life Sciences
Routine Diagnostic Tests Medicine & Life Sciences

Research Output 2004 2012

10 Citations (Scopus)
340 Downloads (Pure)

Restoration of adipose function in obese, glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β upregulation

McGinty, A., Powell, L., Crowe, P., Kankara, C., McPeake, J., McCance, D., Young, I. & Trimble, E., Aug 2012, In : Clinical Science. 123, 3, p. 135–146 12 p.

Research output: Contribution to journalArticle

Open Access
File
pioglitazone
CCAAT-Enhancer-Binding Proteins
Up-Regulation
Macrophages
Monocytes
10 Citations (Scopus)

Synthesis of A83586C analogs with potent anticancer and beta-catenin/ TCF4/osteopontin inhibitory effects and insights into how A83586C modulates E2Fs and pRb.

Hale, K. J., Manaviazar, S., Lazarides, L., George, J., Walters, M. A., Cai, J., Delisser, V. M., Bhatia, G. S., Peak, S. A., Dalby, S. M., Lefranc, A., Chen, Y. P., Wood, A. W., Crowe, P., Erwin, P. & El-Tanani, M., 05 Feb 2009, In : Organic Letters. 11, 3, p. 737-740 4 p.

Research output: Contribution to journalArticle

Osteopontin
beta Catenin
analogs
synthesis
inhibitors
63 Citations (Scopus)

Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation

Mason, C. K., McFarlane, S., Johnston, P., Crowe, P., Erwin, P. J., Domostoj, M. M., Campbell, F., Manaviazar, S., Hale, K. J. & El-Tanani, M., 01 Mar 2008, In : Molecular Cancer Therapeutics. 7, 3, p. 548-558 11 p.

Research output: Contribution to journalArticle

Osteopontin
beta Catenin
Cell Line
Cisplatin
Breast Neoplasms